IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to invest in. On February 3, BTIG lowered its price target on IDEXX Laboratories Inc.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 1,876,035 | $1,269,193,959 | -29% | 7.42% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 550,368 | $372,340,463 | +198% | 0.22% |
| 3. | Select Equity Group Robert Joseph Caruso | 131,386 | $88,886,571 | -54% | 0.38% |
| 4. | AQR Capital Management Cliff Asness | 114,775 | $77,648,881 | -16% | 0.04% |
| 5. | Tremblant Capital Brett Barakett | 65,288 | $44,169,291 | 1.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | $99,903.75 | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | $501,875.40 | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | $100,479.51 | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | $178,045.00 | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | $179,580.00 | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $650.32 | 40 | $26,012.80 | 9,823 | 2026-02-10 | Filing | |
| $649.26 | 2,809 | $1,823,771.06 | 9,863 | 2026-02-10 | Filing | |
| $648.78 | 966 | $626,720.71 | 12,672 | 2026-02-10 | Filing | |
| $647.21 | 1,060 | $686,039.00 | 13,638 | 2026-02-10 | Filing | |
| $646.23 | 2,782 | $1,797,800.45 | 14,698 | 2026-02-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,945,328 | $6,728,312,752 | 0.1% | |
| 2. | 8,534,886 | $5,774,106,652 | 0.1% | |
| 3. | 3,656,626 | $2,473,817,188 | 0.08% | |
| 4. | 2,583,939 | $1,749,379,966 | 0.11% | |
| 5. | 1,798,041 | $1,216,428,678 | 3.3% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers
Baron Fund, an investment management company, released its Q4 2025 letter for “Baron Partners Fund”. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ thesis on IDXX.
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here.
Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability
Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2025 Earnings Conference Call. As a reminder, today's conference is being recorded.
IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
IDEXX Laboratories (IDXX): From a Detractor to a Revivor
Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
